Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCL10 gene mutation in lymphoma.

M Q Du1, H Peng, H Liu

  • 1Department of Histopathology, Royal Free and University College London Medical School, London, United Kingdom. m.du@ucl.ac.uk

Blood
|June 14, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of beta-glucan on oxidative stress, inflammation, hormonal and histopathological changes in dehydroepiandrosterone-induced polycystic ovary syndrome.

Biotechnic & histochemistry : official publication of the Biological Stain Commission·2025
Same author

Determination of periodic deformation from InSAR results using the FFT time series analysis method in Gediz Graben.

Natural hazards (Dordrecht, Netherlands)·2023
Same author

Evaluate the safety and efficacy of dura sealant patch in reducing cerebrospinal fluid leakage following elective cranial surgery (ENCASE II): study protocol for a randomized, two-arm, multicenter trial.

Trials·2022
Same author

Effect of Helicobacter pylori infection on the first-line treatment outcomes in patients with immune thrombocytopenic purpura.

European review for medical and pharmacological sciences·2022
Same author

Preoperative and postoperative ultrasound elastography findings of the sciatic nerve in patients with unilateral lumbar foraminal disc herniation: a pre-test and post-test design.

European review for medical and pharmacological sciences·2022
Same author

The clinicopathological features and survival of Castleman disease: a multicenter Turkish study.

European review for medical and pharmacological sciences·2022

BCL10 gene mutations are linked to B-cell lymphoma development, especially in aggressive MALT lymphomas. These mutations in BCL10 disrupt apoptosis and promote cancer, particularly in cases unresponsive to H. pylori therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The BCL10 gene plays a role in mucosa-associated lymphoid tissue (MALT) lymphoma development.
  • Wild-type BCL10 inhibits malignant transformation, while mutations can lead to enhanced transformation and loss of apoptosis.
  • The t(1;14)(p22;q32) translocation directly involves BCL10 in MALT lymphoma.

Purpose of the Study:

  • To investigate the frequency and characteristics of BCL10 gene mutations in various B-cell lymphomas.
  • To determine the potential pathogenic role of BCL10 mutations in lymphoma development.
  • To explore the correlation between BCL10 mutations and clinical features, such as response to H. pylori eradication therapy in gastric MALT lymphoma.

Main Methods:

  • Genomic DNA analysis of 220 lymphoma specimens using polymerase chain reaction-single-strand conformational polymorphism (PCR-SSCP) and DNA sequencing.

Related Experiment Videos

  • Mutation analysis focused on the BCL10 gene.
  • Western blot analysis was performed on a mutant case to confirm truncated BCL10 protein products.

    • Main Results:

    • Nineteen BCL10 mutations were identified in 13 of 220 lymphoma specimens.
    • Mutation frequencies varied across lymphoma types: 6.7% in MALT lymphomas, 9.5% in follicular lymphomas, and 4.3% in diffuse large B-cell lymphomas.
    • All 14 potentially pathogenic mutations were located in the carboxyl-terminal domain, with deletions causing truncated BCL10 in 10 cases. Notably, mutations were found in gastric MALT lymphomas unresponsive to H. pylori eradication.

    Conclusions:

    • BCL10 mutations may contribute to the pathogenesis of B-cell lymphomas.
    • Mutations are particularly relevant in aggressive and therapy-unresponsive MALT lymphomas.
    • The carboxyl-terminal domain of BCL10 is critical for its function, and mutations here can drive malignant transformation.